LBS logo London experience. World impact.

Search for faculty

Colleen Cunningham

Assistant Professor of Strategy and Entrepreneurship


BA (University of British Columbia) MA (Simon Fraser University) PhD (Duke University)

Dr Colleen Cunningham’s research examines the challenges and advantages of commercialising new-to-the-world inventions. Dr Cunningham is fascinated by markets for technology, specifically the origins of markets and the implications for the selection of novel ideas. Her specialism also spans high technology and entrepreneurship, and medical technologies such as medical devices and pharmaceuticals.

Dr Cunningham was previously a PhD student at the Fuqua School of Business, Duke University. She was also a health policy researcher, publishing 12 peer-reviewed articles on health systems management and policy related to pharmaceuticals. In addition, she was a researcher and policy analyst in Canada for the Government of British Columbia, the Ministry of Economic Development and Ministry of Natural Resource Management.

2013

Racial and ethnic disparities in the use of antipsychotic medicatication: a systematic review and meta-analysis

Puyat J H; Daw J R; Cunningham C M; Law M R; Wong T W; Greyson D L; Morgan S G

Social Psychiatry and Psychiatric Epidemiology 2013 Vol 48:12 p 1861-1872

2012

Information behaviour of Canadian pharmaceutical policy makers

Greyson D L; Cunningham C M; Morgan S

Health Information and Libraries Journal 2012 Vol 29:1 p 16-27

Drug development: innovation or imitation deficit?

Morgan S G; Cunningham C M; Law M R

British Medical Journal 2012 Vol 345

The cost of drug development: a systematic review

Morgan S; Grootendorst P; Lexchin J; Cunningham C; Greyson D

Health Policy 2011 Vol 100:1 p 4-17

Ethnic differences in the use of prescription drugs: a cross-sectional analysis of linked survey and administrative data

Morgan S; Hanley G; Cunningham C; Quan H

Open Medicine 2011 Vol 5:2 p e87-e92

Ethnic disparities in antipsychotic drug use in British Columbia: a cross-sectional retrospective study

Puyat J H; Hanley G E; Cunningham C M; Law M R; Wong S T; Sutherland J M; Morgan S G

Psychiatric Services 2011 Vol 62:9 p 1026-1031

Income inequities in end-of-life health care spending in British Columbia, Canada: a cross-sectional analysis, 2004-2006

Cunningham C M; Hanley G E; Morgan S G

International Journal for Equity in Health 2011 Vol 10:12

Listening for prescriptions: a national consultation on pharmaceutical policy issues

Morgan S; Cunningham C M

Healthcare Policy 2010 Vol 6:2 p 48-66

2009

The British Columbia medical and hospital atlas : a companion to the British Columbia Rx atlas, 2nd edition

Morgan S; Cunningham C M; Hanley G; Mooney D

Centre for Health Services and Policy Research (CHSPR)

The British Columbia Rx atlas, 2nd edition

Morgan S; Cunningham C M; Hanley G; Mooney D

Centre for Health Services and Policy Research (CHSPR)

2008

The effect of evidence-based drug coverage policies on pharmaceutical R&D: a case study from British Columbia

Morgan S; Cunningham C M

Healthcare Policy 2008 Vol 3:3 p e128-e153